VVOS
Vivos Therapeutics Inc
NASDAQ: VVOS · HEALTHCARE · MEDICAL DEVICES
$0.80
+2.26% today
Updated 2026-04-30
Market cap
$11.46M
P/E ratio
—
P/S ratio
0.66x
EPS (TTM)
$-2.07
Dividend yield
—
52W range
$1 – $8
Volume
0.2M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
4.0
Growth
C5.0
Quality
C+2.0
Profitability
F6.7
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$2.42
+202.05%
12-Month target
—
—
Intrinsic (DCF)
$3.68
Margin of safety
+57.88%
0 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ 57.88% below intrinsic value
Risks
- Thin margins at -121.40%
- Negative free cash flow $-4.71M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $16.02M | $13.80M | $15.03M | $17.44M | $17.44M |
| Net income | $-23.84M | $-13.58M | $-11.14M | $-21.23M | $-6.95M |
| EPS | — | — | — | — | $-2.07 |
| Free cash flow | $-20.51M | $-12.75M | $-13.26M | $-17.60M | $-4.71M |
| Profit margin | -148.81% | -98.42% | -74.09% | -121.71% | -121.40% |
Peer comparison
Smart narrative
Vivos Therapeutics Inc trades at $0.80. Our Smart Value Score of 23/100 indicates the stock is weak. TTM revenue stands at $17.44M. with profit margins at -121.40%. Our DCF model estimates intrinsic value at $3.68.
Frequently asked questions
What is Vivos Therapeutics Inc's stock price?
Vivos Therapeutics Inc (VVOS) trades at $0.80.
Is Vivos Therapeutics Inc overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell). DCF value $3.68.
What is the price target of Vivos Therapeutics Inc (VVOS)?
The analyst target price is $2.42, representing +202.0% upside from the current price of $0.80.
What is the intrinsic value of Vivos Therapeutics Inc (VVOS)?
Based on our DCF model, intrinsic value is $3.68, a +57.9% margin of safety versus $0.80.
What is Vivos Therapeutics Inc's revenue?
TTM revenue is $17.44M.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.66x
ROE-663.00%
Beta6.90
50D MA$1.26
200D MA$2.63
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—